

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.63144359 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.51200553 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.73779962 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.64357091 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.64357091 |
| 6 | lipoprotein transport (GO:0042953) | 7.34844901 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28688557 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 7.28688557 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 6.76464830 |
| 10 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.71631030 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.56544991 |
| 12 | intestinal absorption (GO:0050892) | 6.07267400 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.96291189 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.95834611 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 5.95834611 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 5.95834611 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.83946378 |
| 18 | bile acid biosynthetic process (GO:0006699) | 5.74144339 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.73436387 |
| 20 | NADH metabolic process (GO:0006734) | 5.71631146 |
| 21 | regulation of guanylate cyclase activity (GO:0031282) | 5.70081500 |
| 22 | hormone catabolic process (GO:0042447) | 5.68528368 |
| 23 | tryptophan metabolic process (GO:0006568) | 5.63407128 |
| 24 | urea metabolic process (GO:0019627) | 5.57537683 |
| 25 | urea cycle (GO:0000050) | 5.57537683 |
| 26 | phenylpropanoid metabolic process (GO:0009698) | 5.53286057 |
| 27 | glyoxylate metabolic process (GO:0046487) | 5.48189152 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 5.44288462 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.34360980 |
| 30 | omega-hydroxylase P450 pathway (GO:0097267) | 5.30142396 |
| 31 | protein carboxylation (GO:0018214) | 5.27857233 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.27857233 |
| 33 | cysteine metabolic process (GO:0006534) | 5.21679375 |
| 34 | regulation of fibrinolysis (GO:0051917) | 5.19407293 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 5.12285728 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 5.11907206 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 5.09585518 |
| 38 | bile acid metabolic process (GO:0008206) | 5.08731966 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.93433689 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.91177987 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.87160683 |
| 42 | negative regulation of cholesterol transport (GO:0032375) | 4.86215634 |
| 43 | negative regulation of sterol transport (GO:0032372) | 4.86215634 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.84350521 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.84350521 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.84350521 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.80016077 |
| 48 | phospholipid efflux (GO:0033700) | 4.74605450 |
| 49 | regulation of protein activation cascade (GO:2000257) | 4.71790445 |
| 50 | complement activation, alternative pathway (GO:0006957) | 4.70172376 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.68841228 |
| 52 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.68112081 |
| 53 | fructose metabolic process (GO:0006000) | 4.67258583 |
| 54 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.66993701 |
| 55 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.66712777 |
| 56 | endocrine process (GO:0050886) | 4.66712777 |
| 57 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.66712777 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.64169972 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.63814054 |
| 60 | daunorubicin metabolic process (GO:0044597) | 4.62593990 |
| 61 | polyketide metabolic process (GO:0030638) | 4.62593990 |
| 62 | doxorubicin metabolic process (GO:0044598) | 4.62593990 |
| 63 | triglyceride homeostasis (GO:0070328) | 4.60808858 |
| 64 | acylglycerol homeostasis (GO:0055090) | 4.60808858 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 4.58661608 |
| 66 | bile acid and bile salt transport (GO:0015721) | 4.50444324 |
| 67 | lysine metabolic process (GO:0006553) | 4.48418381 |
| 68 | lysine catabolic process (GO:0006554) | 4.48418381 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 4.47945882 |
| 70 | drug catabolic process (GO:0042737) | 4.38911712 |
| 71 | glycine metabolic process (GO:0006544) | 4.35149848 |
| 72 | cellular glucuronidation (GO:0052695) | 4.34761978 |
| 73 | regulation of complement activation (GO:0030449) | 4.33447983 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.30509025 |
| 75 | alkaloid metabolic process (GO:0009820) | 4.29568475 |
| 76 | cholesterol efflux (GO:0033344) | 4.28855639 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 4.26144032 |
| 78 | coenzyme catabolic process (GO:0009109) | 4.23437643 |
| 79 | indolalkylamine metabolic process (GO:0006586) | 4.23386904 |
| 80 | glutamate metabolic process (GO:0006536) | 4.21119490 |
| 81 | ethanol oxidation (GO:0006069) | 4.20697993 |
| 82 | cellular biogenic amine catabolic process (GO:0042402) | 4.18049917 |
| 83 | amine catabolic process (GO:0009310) | 4.18049917 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 4.15566054 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 4.14497328 |
| 86 | virion attachment to host cell (GO:0019062) | 4.11485324 |
| 87 | adhesion of symbiont to host cell (GO:0044650) | 4.11485324 |
| 88 | heme transport (GO:0015886) | 4.10400037 |
| 89 | plasma lipoprotein particle assembly (GO:0034377) | 4.09422007 |
| 90 | digestion (GO:0007586) | 4.09358522 |
| 91 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.08816549 |
| 92 | regulation of systemic arterial blood pressure (GO:0003073) | 4.08567894 |
| 93 | serine family amino acid metabolic process (GO:0009069) | 4.08293804 |
| 94 | negative regulation of steroid metabolic process (GO:0045939) | 4.07565351 |
| 95 | glycoside metabolic process (GO:0016137) | 4.07317255 |
| 96 | fat-soluble vitamin metabolic process (GO:0006775) | 4.05037820 |
| 97 | lipoprotein metabolic process (GO:0042157) | 4.04208794 |
| 98 | cellular modified amino acid catabolic process (GO:0042219) | 4.02010677 |
| 99 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.01409597 |
| 100 | drug transmembrane transport (GO:0006855) | 4.00765347 |
| 101 | arginine metabolic process (GO:0006525) | 3.99901517 |
| 102 | ketone body metabolic process (GO:1902224) | 3.97004459 |
| 103 | short-chain fatty acid metabolic process (GO:0046459) | 3.92580884 |
| 104 | aldehyde catabolic process (GO:0046185) | 3.92564154 |
| 105 | serine family amino acid biosynthetic process (GO:0009070) | 3.91670663 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.90696284 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 3.89651057 |
| 108 | renal system process involved in regulation of blood volume (GO:0001977) | 3.87387419 |
| 109 | fibrinolysis (GO:0042730) | 3.86155706 |
| 110 | vitamin A metabolic process (GO:0006776) | 3.85814244 |
| 111 | glucuronate metabolic process (GO:0019585) | 3.85639341 |
| 112 | uronic acid metabolic process (GO:0006063) | 3.85639341 |
| 113 | phospholipid homeostasis (GO:0055091) | 3.85452081 |
| 114 | peptide hormone processing (GO:0016486) | 3.81101761 |
| 115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.80276737 |
| 116 | drug transport (GO:0015893) | 3.79726290 |
| 117 | flavonoid metabolic process (GO:0009812) | 3.78735052 |
| 118 | cholesterol homeostasis (GO:0042632) | 3.78602231 |
| 119 | drug metabolic process (GO:0017144) | 3.77130774 |
| 120 | cofactor catabolic process (GO:0051187) | 3.76993583 |
| 121 | organic acid catabolic process (GO:0016054) | 3.76765136 |
| 122 | carboxylic acid catabolic process (GO:0046395) | 3.76765136 |
| 123 | drinking behavior (GO:0042756) | 3.76312157 |
| 124 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74428638 |
| 125 | primary alcohol catabolic process (GO:0034310) | 3.73905878 |
| 126 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73487899 |
| 127 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73487899 |
| 128 | acetyl-CoA metabolic process (GO:0006084) | 3.72438786 |
| 129 | sterol homeostasis (GO:0055092) | 3.72198141 |
| 130 | vitamin transport (GO:0051180) | 3.71639231 |
| 131 | blood coagulation, intrinsic pathway (GO:0007597) | 3.70823868 |
| 132 | protein-lipid complex assembly (GO:0065005) | 3.67550953 |
| 133 | plasma lipoprotein particle organization (GO:0071827) | 3.67263751 |
| 134 | vitamin D metabolic process (GO:0042359) | 3.60668141 |
| 135 | adhesion of symbiont to host (GO:0044406) | 3.59696450 |
| 136 | vitamin biosynthetic process (GO:0009110) | 3.59389203 |
| 137 | regulation of cholesterol homeostasis (GO:2000188) | 3.59314054 |
| 138 | mRNA modification (GO:0016556) | 3.58978388 |
| 139 | diacylglycerol metabolic process (GO:0046339) | 3.58142160 |
| 140 | exogenous drug catabolic process (GO:0042738) | 3.57835196 |
| 141 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.55131170 |
| 142 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54315587 |
| 143 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.54315587 |
| 144 | vitamin transmembrane transport (GO:0035461) | 3.47367401 |
| 145 | glycolipid catabolic process (GO:0019377) | 3.45270541 |
| 146 | urate metabolic process (GO:0046415) | 3.44293729 |
| 147 | phenol-containing compound catabolic process (GO:0019336) | 3.44191049 |
| 148 | regulation of vitamin metabolic process (GO:0030656) | 3.41816883 |
| 149 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.41555066 |
| 150 | regulation of cGMP biosynthetic process (GO:0030826) | 3.39591265 |
| 151 | glycosphingolipid catabolic process (GO:0046479) | 3.39141304 |
| 152 | sulfate transmembrane transport (GO:1902358) | 3.38314623 |
| 153 | midgut development (GO:0007494) | 3.35323877 |
| 154 | citrulline biosynthetic process (GO:0019240) | 3.33705340 |
| 155 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.32767006 |
| 156 | oxidative demethylation (GO:0070989) | 3.25924561 |
| 157 | phosphate ion transmembrane transport (GO:0035435) | 3.21591036 |
| 158 | quinone metabolic process (GO:1901661) | 3.21170397 |
| 159 | xenobiotic metabolic process (GO:0006805) | 3.20179401 |
| 160 | intestinal cholesterol absorption (GO:0030299) | 3.14204423 |
| 161 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.11712789 |
| 162 | cyclooxygenase pathway (GO:0019371) | 3.08648374 |
| 163 | peptide catabolic process (GO:0043171) | 3.07772866 |
| 164 | arachidonic acid metabolic process (GO:0019369) | 3.01248005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.42602884 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18813930 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.87214679 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.54298614 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28323430 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.10659490 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.95690140 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98029009 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.97801996 |
| 10 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.40252915 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.40196385 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.22812997 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.22521940 |
| 14 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.09623198 |
| 15 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04378309 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8625700 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97887157 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97711161 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.97012782 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93783402 |
| 21 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.86736625 |
| 22 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.78764445 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61775031 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60390189 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57275821 |
| 26 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.54022903 |
| 27 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40751415 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34821176 |
| 29 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27494004 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26598289 |
| 31 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.21638683 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20856203 |
| 33 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18805939 |
| 34 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17718420 |
| 35 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16597855 |
| 36 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15496228 |
| 37 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13292067 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11257143 |
| 39 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10854251 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08015450 |
| 41 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05274049 |
| 42 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.04857719 |
| 43 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03475090 |
| 44 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02916285 |
| 45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01306305 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99625735 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98097626 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95888303 |
| 49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95865337 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94795023 |
| 51 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93587937 |
| 52 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91922320 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91133085 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89316301 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.89078198 |
| 56 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88343298 |
| 57 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88343298 |
| 58 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86820299 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.86169609 |
| 60 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85519540 |
| 61 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.85204696 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84784175 |
| 63 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.83929708 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83027986 |
| 65 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82937247 |
| 66 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82271900 |
| 67 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82184833 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81866441 |
| 69 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.81316341 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80650500 |
| 71 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80534040 |
| 72 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79348159 |
| 73 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.76753491 |
| 74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.75909465 |
| 75 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75548722 |
| 76 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.74792889 |
| 77 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71912227 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71233029 |
| 79 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.70965169 |
| 80 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.70636206 |
| 81 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69930029 |
| 82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.69342464 |
| 83 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.69049351 |
| 84 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.68969873 |
| 85 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.68822336 |
| 86 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.68822336 |
| 87 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68352987 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67724212 |
| 89 | NFYA_21822215_ChIP-Seq_K562_Human | 0.67676608 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.67105892 |
| 91 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.66861081 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65318438 |
| 93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65062376 |
| 94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65062376 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64266658 |
| 96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63859655 |
| 97 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60902212 |
| 98 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60050238 |
| 99 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59316364 |
| 100 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.58977035 |
| 101 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58904691 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55795139 |
| 103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55410419 |
| 104 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53276158 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52991663 |
| 106 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50595993 |
| 107 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50050072 |
| 108 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49854474 |
| 109 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49299393 |
| 110 | AR_20517297_ChIP-Seq_VCAP_Human | 0.48885689 |
| 111 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48171715 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48063691 |
| 113 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48059731 |
| 114 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47955206 |
| 115 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47675085 |
| 116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46451042 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46226558 |
| 118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.44575237 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43940692 |
| 120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43157611 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42879653 |
| 122 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42306446 |
| 123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.42106396 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41997370 |
| 125 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41548231 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.41547958 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41159143 |
| 128 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40046217 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39863469 |
| 130 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.39376069 |
| 131 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.38922699 |
| 132 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38034331 |
| 133 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.38003513 |
| 134 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37235928 |
| 135 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.36778252 |
| 136 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.36028787 |
| 137 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35584835 |
| 138 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.35434261 |
| 139 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34506740 |
| 140 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.34080569 |
| 141 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33608898 |
| 142 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.33565562 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.33444467 |
| 144 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.32922819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.49239531 |
| 2 | MP0005360_urolithiasis | 7.45335345 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.41192035 |
| 4 | MP0005365_abnormal_bile_salt | 6.15432053 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.44072718 |
| 6 | MP0003183_abnormal_peptide_metabolism | 4.38123882 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.07784802 |
| 8 | MP0003252_abnormal_bile_duct | 3.86131414 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.61511971 |
| 10 | MP0009840_abnormal_foam_cell | 3.42403654 |
| 11 | MP0005083_abnormal_biliary_tract | 3.20850254 |
| 12 | MP0004147_increased_porphyrin_level | 3.18613887 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 3.17998159 |
| 14 | MP0003195_calcinosis | 2.82595552 |
| 15 | MP0005332_abnormal_amino_acid | 2.75182447 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.55104100 |
| 17 | MP0009379_abnormal_foot_pigmentation | 2.48919583 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.19804370 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.17892900 |
| 20 | MP0000609_abnormal_liver_physiology | 2.16149649 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.14617959 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.00838707 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.89364930 |
| 24 | MP0003868_abnormal_feces_composition | 1.87097711 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.80594707 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.74258929 |
| 27 | MP0005451_abnormal_body_composition | 1.68375028 |
| 28 | MP0001764_abnormal_homeostasis | 1.64962616 |
| 29 | MP0005409_darkened_coat_color | 1.64721024 |
| 30 | MP0009697_abnormal_copulation | 1.59664628 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58521920 |
| 32 | MP0001664_abnormal_digestion | 1.48790027 |
| 33 | MP0003011_delayed_dark_adaptation | 1.38418780 |
| 34 | MP0003866_abnormal_defecation | 1.37389369 |
| 35 | MP0003186_abnormal_redox_activity | 1.26208316 |
| 36 | MP0001765_abnormal_ion_homeostasis | 1.25346697 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.22284517 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.21488796 |
| 39 | MP0000538_abnormal_urinary_bladder | 1.16592540 |
| 40 | MP0000598_abnormal_liver_morphology | 1.16231128 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.13416984 |
| 42 | MP0000604_amyloidosis | 1.12157270 |
| 43 | MP0000490_abnormal_crypts_of | 1.10963477 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.09467684 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.06965503 |
| 46 | MP0005647_abnormal_sex_gland | 1.04833413 |
| 47 | MP0009764_decreased_sensitivity_to | 1.03392949 |
| 48 | MP0000477_abnormal_intestine_morphology | 1.01758973 |
| 49 | MP0009763_increased_sensitivity_to | 1.00887665 |
| 50 | MP0002254_reproductive_system_inflammat | 0.96185650 |
| 51 | MP0002098_abnormal_vibrissa_morphology | 0.95864725 |
| 52 | MP0003879_abnormal_hair_cell | 0.94723877 |
| 53 | MP0004043_abnormal_pH_regulation | 0.94501920 |
| 54 | MP0000678_abnormal_parathyroid_gland | 0.87893461 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 0.86861084 |
| 56 | MP0009642_abnormal_blood_homeostasis | 0.86825505 |
| 57 | MP0005408_hypopigmentation | 0.85688903 |
| 58 | MP0008469_abnormal_protein_level | 0.85227407 |
| 59 | MP0005670_abnormal_white_adipose | 0.84964587 |
| 60 | MP0010368_abnormal_lymphatic_system | 0.82269639 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 0.81382460 |
| 62 | MP0001501_abnormal_sleep_pattern | 0.80853793 |
| 63 | MP0002396_abnormal_hematopoietic_system | 0.80585563 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 0.80131468 |
| 65 | MP0009765_abnormal_xenobiotic_induced | 0.79987929 |
| 66 | MP0005376_homeostasis/metabolism_phenot | 0.78132765 |
| 67 | MP0000462_abnormal_digestive_system | 0.76029110 |
| 68 | MP0005501_abnormal_skin_physiology | 0.74866565 |
| 69 | MP0002971_abnormal_brown_adipose | 0.74839830 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.74588903 |
| 71 | MP0000566_synostosis | 0.74046796 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 0.73636239 |
| 73 | MP0005334_abnormal_fat_pad | 0.72970951 |
| 74 | MP0004130_abnormal_muscle_cell | 0.70415684 |
| 75 | MP0003690_abnormal_glial_cell | 0.70207393 |
| 76 | MP0001873_stomach_inflammation | 0.69010224 |
| 77 | MP0001661_extended_life_span | 0.68574718 |
| 78 | MP0001188_hyperpigmentation | 0.67979477 |
| 79 | MP0003329_amyloid_beta_deposits | 0.66980203 |
| 80 | MP0001663_abnormal_digestive_system | 0.66836735 |
| 81 | MP0004858_abnormal_nervous_system | 0.65876181 |
| 82 | MP0009053_abnormal_anal_canal | 0.65235437 |
| 83 | MP0005535_abnormal_body_temperature | 0.64915845 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.64585159 |
| 85 | MP0005266_abnormal_metabolism | 0.63850476 |
| 86 | MP0001756_abnormal_urination | 0.62273050 |
| 87 | MP0006138_congestive_heart_failure | 0.60843272 |
| 88 | MP0005448_abnormal_energy_balance | 0.60779150 |
| 89 | MP0000639_abnormal_adrenal_gland | 0.60502967 |
| 90 | MP0002938_white_spotting | 0.60247047 |
| 91 | MP0005381_digestive/alimentary_phenotyp | 0.56056934 |
| 92 | MP0002822_catalepsy | 0.55340487 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.54899353 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.54111234 |
| 95 | MP0004270_analgesia | 0.50782097 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.50296395 |
| 97 | MP0008874_decreased_physiological_sensi | 0.49276298 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.48962917 |
| 99 | MP0005395_other_phenotype | 0.47778171 |
| 100 | MP0008873_increased_physiological_sensi | 0.46646247 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.46208464 |
| 102 | MP0003718_maternal_effect | 0.43880012 |
| 103 | MP0003436_decreased_susceptibility_to | 0.43543050 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.43177444 |
| 105 | MP0003953_abnormal_hormone_level | 0.42587210 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.42316326 |
| 107 | MP0005248_abnormal_Harderian_gland | 0.42093182 |
| 108 | MP0008872_abnormal_physiological_respon | 0.42068371 |
| 109 | MP0003075_altered_response_to | 0.41796185 |
| 110 | MP0001216_abnormal_epidermal_layer | 0.41063363 |
| 111 | MP0000537_abnormal_urethra_morphology | 0.41048974 |
| 112 | MP0002928_abnormal_bile_duct | 0.40459098 |
| 113 | MP0003724_increased_susceptibility_to | 0.40382060 |
| 114 | MP0000427_abnormal_hair_cycle | 0.39082242 |
| 115 | MP0009672_abnormal_birth_weight | 0.38805779 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.38087997 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.36255558 |
| 118 | MP0002135_abnormal_kidney_morphology | 0.36218196 |
| 119 | MP0001243_abnormal_dermal_layer | 0.35754948 |
| 120 | MP0009115_abnormal_fat_cell | 0.34951881 |
| 121 | MP0004947_skin_inflammation | 0.34682402 |
| 122 | MP0000249_abnormal_blood_vessel | 0.34155301 |
| 123 | MP0002168_other_aberrant_phenotype | 0.34026197 |
| 124 | MP0002970_abnormal_white_adipose | 0.32795474 |
| 125 | MP0001853_heart_inflammation | 0.32311574 |
| 126 | MP0005023_abnormal_wound_healing | 0.32105471 |
| 127 | MP0004883_abnormal_blood_vessel | 0.32011145 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.31921621 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.31450264 |
| 130 | MP0002090_abnormal_vision | 0.31331470 |
| 131 | MP0006082_CNS_inflammation | 0.30231500 |
| 132 | MP0002796_impaired_skin_barrier | 0.29514618 |
| 133 | MP0005166_decreased_susceptibility_to | 0.29281618 |
| 134 | MP0001845_abnormal_inflammatory_respons | 0.27897941 |
| 135 | MP0001881_abnormal_mammary_gland | 0.26971170 |
| 136 | MP0005167_abnormal_blood-brain_barrier | 0.24697583 |
| 137 | MP0000579_abnormal_nail_morphology | 0.24641208 |
| 138 | MP0005164_abnormal_response_to | 0.23550580 |
| 139 | MP0005058_abnormal_lysosome_morphology | 0.23128172 |
| 140 | MP0002060_abnormal_skin_morphology | 0.22779557 |
| 141 | MP0003300_gastrointestinal_ulcer | 0.21765945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.59941388 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.46345530 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.10208867 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.75322541 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.68516362 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.45012622 |
| 7 | Xanthomatosis (HP:0000991) | 6.29777607 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.81172223 |
| 9 | Hypolipoproteinemia (HP:0010981) | 4.90837407 |
| 10 | Joint hemorrhage (HP:0005261) | 4.78203516 |
| 11 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.69691598 |
| 12 | Hyperammonemia (HP:0001987) | 4.65795315 |
| 13 | Widely patent fontanelles and sutures (HP:0004492) | 4.60199914 |
| 14 | Epidermoid cyst (HP:0200040) | 4.53336312 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.50346367 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.43883611 |
| 17 | Hyperglycinemia (HP:0002154) | 4.39015039 |
| 18 | Complement deficiency (HP:0004431) | 4.37881892 |
| 19 | Abnormality of vitamin B metabolism (HP:0004340) | 4.36662788 |
| 20 | Ketosis (HP:0001946) | 4.30407905 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.28940087 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.24629665 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.23259312 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.22698803 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.21536660 |
| 26 | Chronic diarrhea (HP:0002028) | 4.12002906 |
| 27 | Confusion (HP:0001289) | 4.04249440 |
| 28 | Ileus (HP:0002595) | 4.00143479 |
| 29 | Hyperglycinuria (HP:0003108) | 3.99564006 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.96684570 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.96684570 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.93128914 |
| 33 | Fat malabsorption (HP:0002630) | 3.92949110 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.92426837 |
| 35 | Abnormality of urine glucose concentration (HP:0011016) | 3.87172576 |
| 36 | Glycosuria (HP:0003076) | 3.87172576 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.81638842 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.75282731 |
| 39 | Hyperactive renin-angiotensin system (HP:0000841) | 3.65538616 |
| 40 | Abnormality of the intrinsic pathway (HP:0010989) | 3.60566234 |
| 41 | Pigmentary retinal degeneration (HP:0001146) | 3.53786458 |
| 42 | Thin bony cortex (HP:0002753) | 3.46623229 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.46598002 |
| 44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39823034 |
| 45 | Proximal tubulopathy (HP:0000114) | 3.38681017 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.37015470 |
| 47 | Hyperuricemia (HP:0002149) | 3.28435984 |
| 48 | Increased purine levels (HP:0004368) | 3.28435984 |
| 49 | Abnormal urine phosphate concentration (HP:0012599) | 3.20846477 |
| 50 | Abnormality of complement system (HP:0005339) | 3.18289478 |
| 51 | Wide cranial sutures (HP:0010537) | 3.17513011 |
| 52 | Abdominal distention (HP:0003270) | 3.16794262 |
| 53 | Delayed CNS myelination (HP:0002188) | 3.15669540 |
| 54 | Nephrolithiasis (HP:0000787) | 3.13072167 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 3.11748428 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 3.08606987 |
| 57 | Ketoacidosis (HP:0001993) | 3.08268767 |
| 58 | Megaloblastic anemia (HP:0001889) | 3.00738098 |
| 59 | Nausea (HP:0002018) | 2.97096493 |
| 60 | Decreased circulating renin level (HP:0003351) | 2.97053589 |
| 61 | Facial shape deformation (HP:0011334) | 2.95859198 |
| 62 | Potter facies (HP:0002009) | 2.95859198 |
| 63 | Hyperphosphaturia (HP:0003109) | 2.95468250 |
| 64 | Hypophosphatemia (HP:0002148) | 2.93631664 |
| 65 | Hepatocellular carcinoma (HP:0001402) | 2.93134921 |
| 66 | Myocardial infarction (HP:0001658) | 2.92470470 |
| 67 | Steatorrhea (HP:0002570) | 2.90302479 |
| 68 | Enlarged epiphyses (HP:0010580) | 2.83564286 |
| 69 | Focal segmental glomerulosclerosis (HP:0000097) | 2.81382869 |
| 70 | Metabolic acidosis (HP:0001942) | 2.81361171 |
| 71 | Skin nodule (HP:0200036) | 2.79334281 |
| 72 | Spontaneous abortion (HP:0005268) | 2.77865617 |
| 73 | Hypochromic microcytic anemia (HP:0004840) | 2.71913024 |
| 74 | Abnormality of purine metabolism (HP:0004352) | 2.71409224 |
| 75 | Vascular calcification (HP:0004934) | 2.70077775 |
| 76 | Osteomalacia (HP:0002749) | 2.66544455 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66271134 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 2.66271134 |
| 79 | Delayed epiphyseal ossification (HP:0002663) | 2.64577383 |
| 80 | Acanthocytosis (HP:0001927) | 2.63863687 |
| 81 | Lethargy (HP:0001254) | 2.62459299 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.56413377 |
| 83 | Hypoglycemic seizures (HP:0002173) | 2.53285901 |
| 84 | Renal tubular dysfunction (HP:0000124) | 2.53149502 |
| 85 | Spastic diplegia (HP:0001264) | 2.48693070 |
| 86 | Right ventricular cardiomyopathy (HP:0011663) | 2.47997951 |
| 87 | Glomerulonephritis (HP:0000099) | 2.46124641 |
| 88 | Cholelithiasis (HP:0001081) | 2.45283485 |
| 89 | Cholecystitis (HP:0001082) | 2.44331184 |
| 90 | Abnormal gallbladder physiology (HP:0012438) | 2.44331184 |
| 91 | Cerebral edema (HP:0002181) | 2.43241276 |
| 92 | Mitral stenosis (HP:0001718) | 2.43061743 |
| 93 | Irritability (HP:0000737) | 2.40821392 |
| 94 | Metabolic alkalosis (HP:0200114) | 2.40451255 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.39766674 |
| 96 | Abnormality of renin-angiotensin system (HP:0000847) | 2.36651471 |
| 97 | Systemic lupus erythematosus (HP:0002725) | 2.33153737 |
| 98 | Gout (HP:0001997) | 2.31322972 |
| 99 | Malnutrition (HP:0004395) | 2.31180085 |
| 100 | Amyloidosis (HP:0011034) | 2.28367556 |
| 101 | Renal tubular acidosis (HP:0001947) | 2.28223420 |
| 102 | Posterior subcapsular cataract (HP:0007787) | 2.26864432 |
| 103 | Neonatal onset (HP:0003623) | 2.24407978 |
| 104 | Esophageal varix (HP:0002040) | 2.23429888 |
| 105 | Menorrhagia (HP:0000132) | 2.20345126 |
| 106 | Abnormality of the costochondral junction (HP:0000919) | 2.18670101 |
| 107 | Brushfield spots (HP:0001088) | 2.18327583 |
| 108 | Glomerulosclerosis (HP:0000096) | 2.17994258 |
| 109 | Late onset (HP:0003584) | 2.14714754 |
| 110 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.11205371 |
| 111 | Gingival bleeding (HP:0000225) | 2.10834749 |
| 112 | Pancreatitis (HP:0001733) | 2.08064999 |
| 113 | Vomiting (HP:0002013) | 2.08032759 |
| 114 | Subcapsular cataract (HP:0000523) | 2.08026487 |
| 115 | Poikilocytosis (HP:0004447) | 2.07236044 |
| 116 | Generalized aminoaciduria (HP:0002909) | 2.05730928 |
| 117 | Abnormality of the gallbladder (HP:0005264) | 2.04508982 |
| 118 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.04111413 |
| 119 | Enlarged kidneys (HP:0000105) | 2.03365076 |
| 120 | Sensorimotor neuropathy (HP:0007141) | 2.01937633 |
| 121 | Opisthotonus (HP:0002179) | 2.01669476 |
| 122 | Elevated alkaline phosphatase (HP:0003155) | 2.00692328 |
| 123 | Thrombophlebitis (HP:0004418) | 2.00153570 |
| 124 | Hypotension (HP:0002615) | 1.99962363 |
| 125 | Hyperparathyroidism (HP:0000843) | 1.99696273 |
| 126 | Hydroxyprolinuria (HP:0003080) | 1.98958827 |
| 127 | Abnormality of proline metabolism (HP:0010907) | 1.98958827 |
| 128 | Villous atrophy (HP:0011473) | 1.98404299 |
| 129 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.98404299 |
| 130 | Hemorrhage of the eye (HP:0011885) | 1.97234918 |
| 131 | Abnormal cartilage morphology (HP:0002763) | 1.94874556 |
| 132 | Rickets (HP:0002748) | 1.94743356 |
| 133 | Alkalosis (HP:0001948) | 1.94403729 |
| 134 | Renal cortical cysts (HP:0000803) | 1.89766915 |
| 135 | Cerebral palsy (HP:0100021) | 1.89270899 |
| 136 | Dehydration (HP:0001944) | 1.88568273 |
| 137 | Protuberant abdomen (HP:0001538) | 1.88138612 |
| 138 | Hypophosphatemic rickets (HP:0004912) | 1.87851213 |
| 139 | Abnormal glucose tolerance (HP:0001952) | 1.85552279 |
| 140 | Abnormality of iron homeostasis (HP:0011031) | 1.83987109 |
| 141 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83078289 |
| 142 | Reticulocytosis (HP:0001923) | 1.82080384 |
| 143 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81338799 |
| 144 | Status epilepticus (HP:0002133) | 1.80226173 |
| 145 | Flat acetabular roof (HP:0003180) | 1.79950999 |
| 146 | Abnormality of vitamin metabolism (HP:0100508) | 1.77902521 |
| 147 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77869777 |
| 148 | Elevated hepatic transaminases (HP:0002910) | 1.77284135 |
| 149 | Nephritis (HP:0000123) | 1.75974060 |
| 150 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.73175145 |
| 151 | Hyperaldosteronism (HP:0000859) | 1.71916379 |
| 152 | Gingivitis (HP:0000230) | 1.70358493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 8.44284370 |
| 2 | BCKDK | 7.13239334 |
| 3 | SIK1 | 4.82767778 |
| 4 | FGFR4 | 4.33254861 |
| 5 | ERN1 | 3.89957700 |
| 6 | PRKG2 | 3.20889023 |
| 7 | EPHA2 | 3.14680112 |
| 8 | PKN2 | 3.09282322 |
| 9 | TAOK3 | 2.99544454 |
| 10 | INSRR | 2.98578526 |
| 11 | MST4 | 2.78111318 |
| 12 | MAP3K2 | 2.68839252 |
| 13 | STK39 | 2.48800643 |
| 14 | MAP3K12 | 2.45627123 |
| 15 | FLT3 | 2.42152695 |
| 16 | MAP2K4 | 2.28413654 |
| 17 | ERBB4 | 2.20316916 |
| 18 | MST1R | 2.15060454 |
| 19 | PIK3CG | 1.83914926 |
| 20 | OXSR1 | 1.83502240 |
| 21 | TYK2 | 1.77667334 |
| 22 | TRIB3 | 1.77510582 |
| 23 | AKT3 | 1.72194036 |
| 24 | DAPK2 | 1.67442922 |
| 25 | MAPK11 | 1.57642314 |
| 26 | LATS1 | 1.52577962 |
| 27 | ABL2 | 1.51279631 |
| 28 | PTK6 | 1.48667559 |
| 29 | FRK | 1.43665033 |
| 30 | STK24 | 1.43624971 |
| 31 | TNIK | 1.42709740 |
| 32 | FGFR2 | 1.40890168 |
| 33 | LMTK2 | 1.33921924 |
| 34 | KDR | 1.33024809 |
| 35 | MAP3K7 | 1.28568717 |
| 36 | NEK9 | 1.27775174 |
| 37 | PRKAA2 | 1.27619424 |
| 38 | JAK2 | 1.20550831 |
| 39 | CAMK1D | 1.15281742 |
| 40 | MYLK | 1.15220576 |
| 41 | EPHB2 | 1.12958096 |
| 42 | PINK1 | 1.11809305 |
| 43 | MAP3K14 | 1.10485403 |
| 44 | TBK1 | 1.10368897 |
| 45 | MAP2K3 | 1.08792993 |
| 46 | GRK6 | 1.06817829 |
| 47 | PDK2 | 1.05204867 |
| 48 | PAK4 | 1.03848703 |
| 49 | MAPK4 | 1.00839087 |
| 50 | JAK1 | 1.00625894 |
| 51 | PIM1 | 0.99897971 |
| 52 | MAP3K10 | 0.94750355 |
| 53 | PRKCZ | 0.93917218 |
| 54 | TESK2 | 0.92070265 |
| 55 | CSK | 0.88679009 |
| 56 | ERBB2 | 0.85919450 |
| 57 | MAP3K3 | 0.85871133 |
| 58 | BRSK2 | 0.85731157 |
| 59 | MET | 0.82025459 |
| 60 | PRKACG | 0.81159808 |
| 61 | IRAK1 | 0.79714667 |
| 62 | MAPK12 | 0.79524885 |
| 63 | EPHB1 | 0.78912848 |
| 64 | CDK6 | 0.78673409 |
| 65 | MAPK15 | 0.75301539 |
| 66 | STK38L | 0.74484887 |
| 67 | DYRK1B | 0.74313723 |
| 68 | MAP2K6 | 0.71218069 |
| 69 | MAP3K11 | 0.70849934 |
| 70 | TIE1 | 0.70792294 |
| 71 | TGFBR2 | 0.68916831 |
| 72 | PRKAA1 | 0.68676761 |
| 73 | GSK3A | 0.66488881 |
| 74 | SGK3 | 0.64011678 |
| 75 | CSF1R | 0.60720451 |
| 76 | BMPR2 | 0.60596486 |
| 77 | RPS6KB2 | 0.60134170 |
| 78 | RIPK1 | 0.59121759 |
| 79 | EPHA4 | 0.58895124 |
| 80 | CAMK2G | 0.58762418 |
| 81 | FER | 0.58302763 |
| 82 | IKBKE | 0.57211825 |
| 83 | MAPK7 | 0.56578293 |
| 84 | NLK | 0.55927797 |
| 85 | CASK | 0.55389957 |
| 86 | CAMK2D | 0.55061306 |
| 87 | PDPK1 | 0.54120502 |
| 88 | CSNK1G1 | 0.54059578 |
| 89 | PTK2 | 0.53908551 |
| 90 | PRKCQ | 0.53903768 |
| 91 | EPHA3 | 0.53860580 |
| 92 | CAMK1G | 0.53549817 |
| 93 | NEK1 | 0.53141635 |
| 94 | IRAK3 | 0.52400671 |
| 95 | MAP3K13 | 0.52226193 |
| 96 | FGFR3 | 0.51881574 |
| 97 | YES1 | 0.51620773 |
| 98 | RET | 0.51146539 |
| 99 | CAMK2B | 0.48240105 |
| 100 | PRKCD | 0.47149923 |
| 101 | TAOK2 | 0.46419136 |
| 102 | MATK | 0.45540079 |
| 103 | IGF1R | 0.45346645 |
| 104 | SGK2 | 0.45225914 |
| 105 | MELK | 0.43041022 |
| 106 | PIM2 | 0.42670300 |
| 107 | MAP2K1 | 0.41439903 |
| 108 | SCYL2 | 0.41400711 |
| 109 | GRK1 | 0.41041594 |
| 110 | PDK1 | 0.41008644 |
| 111 | PRKCI | 0.39600739 |
| 112 | MAP3K6 | 0.38879185 |
| 113 | SRC | 0.38807840 |
| 114 | DDR2 | 0.38691707 |
| 115 | PBK | 0.37707349 |
| 116 | CSNK1G2 | 0.37598123 |
| 117 | MAP3K5 | 0.37557531 |
| 118 | ICK | 0.37398607 |
| 119 | CDK4 | 0.37172659 |
| 120 | PRKCG | 0.36738309 |
| 121 | FYN | 0.35369577 |
| 122 | CAMKK1 | 0.34487156 |
| 123 | CDC42BPA | 0.34438774 |
| 124 | MTOR | 0.34127427 |
| 125 | CSNK1G3 | 0.33548290 |
| 126 | CAMK4 | 0.32813771 |
| 127 | SGK494 | 0.31849558 |
| 128 | SGK223 | 0.31849558 |
| 129 | TESK1 | 0.31273849 |
| 130 | EGFR | 0.29736412 |
| 131 | MAPKAPK3 | 0.29694448 |
| 132 | PDK3 | 0.28707259 |
| 133 | PDK4 | 0.28707259 |
| 134 | PRKCA | 0.28093867 |
| 135 | MAPKAPK2 | 0.27568505 |
| 136 | NEK6 | 0.27355428 |
| 137 | CSNK1A1L | 0.26284952 |
| 138 | PIK3CA | 0.25707106 |
| 139 | PRKACA | 0.25408052 |
| 140 | BCR | 0.25195506 |
| 141 | IRAK2 | 0.25166148 |
| 142 | PRKG1 | 0.25118972 |
| 143 | MAP2K2 | 0.24566475 |
| 144 | TAOK1 | 0.22450376 |
| 145 | AURKB | 0.22396826 |
| 146 | AKT2 | 0.22356792 |
| 147 | MAP3K1 | 0.21568017 |
| 148 | PRKCE | 0.21126161 |
| 149 | FGFR1 | 0.20713928 |
| 150 | ABL1 | 0.20658983 |
| 151 | PRKCB | 0.20577256 |
| 152 | CDK9 | 0.19934581 |
| 153 | IRAK4 | 0.19738089 |
| 154 | BMPR1B | 0.18506003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.30558175 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.59981078 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39423180 |
| 4 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35664742 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04586512 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.01731976 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70016515 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60345437 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55836477 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52336529 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47155505 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40707182 |
| 13 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19732018 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19598425 |
| 15 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16029651 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07113472 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.02534277 |
| 18 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97793486 |
| 19 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.96828892 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95556892 |
| 21 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94575573 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91916947 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90944041 |
| 24 | Mineral absorption_Homo sapiens_hsa04978 | 1.89422780 |
| 25 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83819984 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81473341 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75902681 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73649560 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72412246 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70522644 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68284812 |
| 32 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66736544 |
| 33 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.62799850 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57626142 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56880228 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.54025970 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49349703 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49233876 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46166106 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41860036 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41065644 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39447347 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.37080716 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28827524 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.22010750 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20459886 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18411994 |
| 48 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18314048 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17693452 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16361581 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04446624 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04284970 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99936292 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99310822 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97475297 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88216317 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87322930 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85069897 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.84277975 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84095790 |
| 61 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80339110 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75286416 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74769419 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73799477 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70827182 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66353885 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65170157 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62522284 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62089541 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60196774 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51580179 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47253152 |
| 73 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46113563 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30410876 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27470218 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26695481 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26377946 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26070671 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25129976 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.23820999 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23673349 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16400818 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.13010187 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.10732923 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10405497 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.08874052 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.05739174 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.04457691 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02854447 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.01616405 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2527485 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2466296 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2432864 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2353831 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2335333 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2301640 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2093742 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2032502 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | -0.2027389 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1803489 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1753446 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1635846 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1618993 |
| 104 | Pertussis_Homo sapiens_hsa05133 | -0.1576357 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1549336 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | -0.1491118 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1442780 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1339520 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1147761 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1129410 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1114264 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.1107040 |
| 113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0983944 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0871917 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0836350 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | -0.0718062 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0550059 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0171909 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0030605 |

